A higher risk of HF hospitalization was seen with dapagliflozin over empagliflozin, but one researcher urges caution.
While intensity didn’t appear to matter in this network meta-analysis, location did: in-person programs had the most impact.
It’s not yet time to abandon seated BP measurements, but taking a look at supine readings may provide enhanced risk ...
Following the recent IDE Approval by the U.S. Food and Drug Administration (FDA) for MagicTouch PTA, this enrolment heralds ...